Todd Przybycien, Ph.D., professor of chemical and biological engineering at RPI, has been named head of RPI’s Howard P. Isermann Department of Chemical and Biological Engineering (CBE). Under Przybycien’s leadership, the department will continue to drive innovation in sustainable biopharmaceutical manufacturing, metabolic and enzyme engineering, advanced materials development, transport processes, and process systems engineering.  

RPI School of Engineering has named R. Helen Zha, Ph.D., as a Dean’s Faculty Fellow, recognizing her exceptional accomplishments in research, education, and service.

The Howard P. Isermann Department of Chemical and Biological Engineering, in partnership with the School of Engineering at Rensselaer Polytechnic Institute (RPI), is proud to announce Mattheos Koffas, Ph.D., as the recipient of the inaugural Feltham ReEqu

Rensselaer Polytechnic Institute (RPI) has received a $10 million gift from Ajit Prabhu ’98, founder and CEO of Quest Global, to establish the Ajit Prabhu Catalyst Endowment and the Ajit Prabhu Catalyst Fund, both in support of the Office of Strategic Alliances and Translation (OSAT). Prabhu launched the fund, which will assist RPI student and faculty entrepreneurs.

Rensselaer Polytechnic Institute’s Georges Belfort, Ph.D., and Steven Cramer, Ph.D., both Institute Professors of Chemical and Biological Engineering, have won the 2025 Bernard M. Gordon Prize for Innovation in Engineering and Technology Education given by the National Academy of Engineering. 

Biotechnology researchers at Rensselaer Polytechnic Institute (RPI) are working to further improve mRNA therapeutics, with the aim of reducing manufacturing costs and enabling additional therapeutic uses for mRNA technology.

Rensselaer Polytechnic Institute (RPI) researchers are part of a multi-institution team working to bring rubber production to the United States and better secure the supply chain for this critical material.

Rensselaer Polytechnic Institute’s Boleslaw Szymanski, Ph.D., and Chunyu Wang, M.D. Ph.D., have been elected fellows of the American Association for the Advancement Science (AAAS). Steven Cramer, Ph.D., who was elected AAAS Fellow in 2017, was elected Council Member of the Section on Engineering.

Heparin, the world’s most widely used blood thinner, is used during procedures ranging from kidney dialysis to open heart surgery. Currently, heparin is derived from pig intestines, but scientists at Rensselaer Polytechnic Institute have discovered how to make it in the lab. They have also developed a path to a biomanufacturing process that could potentially revolutionize how the world gets its supply of this crucial medicine.